Kneat Announces Appointment Of European Sales Director
HALIFAX, Nov. 3, 2016 /CNW/ – kneat.com, inc. (TSXV: KSI) (“kneat.com“, “Kneat” or the “Company“) is pleased to announce the appointment of Mr. Mark Geldard as its European Sales Director. Mr. Geldard will lead the Company’s sales and marketing activities throughout Europe. With over 23 years of experience in sales, marketing and business development within the software and IT services industry, Mr. Geldard is ideally suited for this position. Most recently he held the position of Senior Account Manager Life Sciences at NNIT A/S in Zurich, Switzerland. “Mark has a record of success and excellence, and combines extensive experience within both the software and life science industries,” said Eddie Ryan, CEO of Kneat. “We are pleased to welcome Mark to the team and look forward to working with him as we roll out our sales and marketing strategy in Europe.” “I’m excited to join Kneat as I see huge market potential for its software platform within the pharmaceutical industry in Europe,” said Mr. Geldard. “Kneat’s software provides an effective solution to the industry, and I am looking forward to working with clients who will benefit from this innovative product.”
kneat.com develops and markets the leading edge Kneat Gx platform software that meets the stringent pharmaceutical industry regulatory requirements for all forms of validation, equipment changeover management, risk lifecycle management, change control and much more. It has been designed to allow the customer to configure and manage many regulated data and document processes in a paper-less environment.
Cautionary and Forward-Looking Statements
Except for the statements of historical fact contained herein, certain information presented constitutes “forward-looking information” within the meaning of applicable Canadian securities laws. Such forward-looking information, includes, but is not limited to, the ability to generate sales of the Kneat Gx platform, the ability to build relationships with current and prospective customers, the market potential for the Kneat Gx platform and the compliance of the Kneat Gx platform under regulatory audit and inspection. While such forward-looking statements are expressed by the Company, as stated in this release, in good faith and believed by the Company to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties. The Company does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor’s own risk.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE kneat.com For further information: Sarah Oliver, CFO, kneat.com, inc., 2001-1969 Upper Water Street, Halifax, NS, B3J 3R7, T: +353 61 203826, E: firstname.lastname@example.org